Faculty Collaboration Database

Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination. Haematologica 2023 Jan 01;108(1):250-256

Date

09/16/2022

Pubmed ID

36106394

Pubmed Central ID

PMC9827178

DOI

10.3324/haematol.2022.281309

Scopus ID

2-s2.0-85145424654 (requires institutional sign-in at Scopus site)   1 Citation

Author List

Chhabra S, Szabo A, Clurman A, McShane K, Waters N, Eastwood D, Samanas L, Fei T, Armijo G, Abedin S, Longo W, Hari P, Hamadani M, Shah NN, Runaas L, Jerkins JH, Van den Brink M, Peled JU, Drobyski WR

Authors

Sameem Abedin MD Associate Professor in the Medicine department at Medical College of Wisconsin
William R. Drobyski MD Professor in the Medicine department at Medical College of Wisconsin
Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of Wisconsin
Lyndsey Runaas MD Assistant Professor in the Medicine department at Medical College of Wisconsin
Nirav N. Shah MD Associate Professor in the Medicine department at Medical College of Wisconsin
Aniko Szabo PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Antibodies, Monoclonal, Humanized
Gastrointestinal Tract
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Humans